Pure red cell aplasia associated with hepatitis C infection

American Journal of the Medical Sciences

Volumn 314, Issue 2, 1997, Pages 113-117

  Al Awami, Yusra ^a   Sears, David A ^a,c   Carrum, George ^a   Udden, Mark M ^a   Alter, Blanche P ^b   Conlon, Charles L ^a  

^a BEN TAUB GENERAL HOSPITAL   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Erythroid colony formation; Hepatitis C; Pure red cell aplasia

Indexed keywords

CYCLOPHOSPHAMIDE; PREDNISONE;

ADULT; ARTICLE; AUTOIMMUNITY; BURST FORMING UNIT E; CASE REPORT; COLONY FORMATION; COLONY FORMING UNIT; DIAGNOSIS; ERYTHROCYTE APLASIA; FEMALE; HEPATITIS C; HUMAN; HUMAN CELL; HUMAN TISSUE; PORPHYRIA CUTANEA TARDA; SERODIAGNOSIS; SIDEROSIS;

EID: 0030875034     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-199708000-00013     Document Type: Article

References (48)

1. Young N, Mortimer P. Viruses and bone marrow failure. Blood. 1984;68:729-37.
2. Jandl JH. Blood, Textbook of Hematology. Little Brown & Co., 2nd ed; 1996:219-20.
3. Bottiger LE, Westerholm B. Aplastic anaemia. III. Aplastic anaemia and infectious hepatitis. Acta Med Scand. 1972; 192:323-6.
4. Hibb JR, Frickhofen N, Rosenfeld SJ, Feinstone SM, Kojima S, Bacigalupo A, Locasciulli A, et al. Aplastic anemia and viral hepatitis. Non-A, Non-B, Non-C? JAMA. 1992;267:2051-4.
5. Young NS, Alter BP. Aplastic Anemia, Acquired and Inherited. WB Saunders Co., 1994:133-58.
6. Nagarajo M, Weitzman S, Baumann G. Viral hepatitis and agranulocytosis. Amer J Digest Dis. 1973;18:247-52.
7. Hoffman R. Acquired pure amegakaryocytic thrombocytopenic purpura. Semin Hematol. 1991;28:303-12.
8. Jurgensen JC, Abraham JP, Hardy WW. Erythroid aplasia after halothane hepatitis. Report of a case. Dig Dis. 1970;15:577-81.
9. Jeong Y-G, Jung Y, River GL. Pure RBC aplasia and diphenylhydantoin. JAMA. 1974;229:314-5.
10. Krivoy N, Ben-Arieh Y, Carter A, Alroy G. Methazolamide-induced hepatitis and pure RBC aplasia. Arch Int Med. 1981;141:1229-30.
11. Hansen RM, Varma RR, Hanson GA. Gold induced hepatitis and pure red cell aplasia. Complete recovery after corticosteroid and N-acetylcysteine therapy. J Rheumatol. 1991;18:1251-3.
12. Veale KS, Huff ES, Nelson BK, Coffman DS. Pure red cell aplasia and hepatitis in a child receiving isoniazid therapy. J Pediatr. 1992;120:146-8.
13. Gundersen SG, Bjoerneklett A, Bruun JN. Severe erythroblastopenia and hemolytic anemia during a hepatitis A infection. Scand J Infect Dis. 1989;21:225-8.
14. Darchis I, Colombel JF, Cortot A, Morel A, Devienne A, Bauters F, Paris JC. Pure red cell aplasia during the course of virus A hepatitis (letter). Gastroenterol Clin Biol. 1990;14:1027.
15. Simmons J, Stein L, Kaufman A. Pure red cell aplasia and hepatitis A. South Med J. 1993;86:1274-6.
16. Ide T, Sata M, Nouno R, Yamashita F, Nakano H, Tanikawa K. Clinical evaluation of four cases of acute viral hepatitis complicated by pure red cell aplasia. Am J Gastroenterol. 1994;89:257-62.
17. Sears DA, George JN, Gold MS. Transient red blood cell aplasia in association with viral hepatitis. Occurrence four years apart in siblings. Arch Int Med. 1975;135:1585-9.
18. Iacopino P, Ronco F, Oliva A, Neri A. Pure red cell aplasia and acute viral hepatitis. Case report and review of the literature. Haematologica. 1986;71:217-20.
19. Zaentz SD, Krantz SB, Sears DA. Studies on pure red cell aplasia. VII. Presence of proerythoblasts and response to splenectomy: A case report. Blood. 1975;46:261-70.
20. Fox RM, Firkin FC. Sequential pure red cell and megakaryocyte aplasia associated with chronic liver disease and ulcerative colitis. Am J Hematol. 1978;4:79-85.
21. Wilson HA, McLaren GD, Dworken HJ, Tebbi K. Transient pure red-cell aplasia: Cell-mediated suppression of erythropoiesis associated with hepatitis. Ann Int Med. 1980;92:196-8.
22. Gonzalez N, Escudero A, Olmeda F, Fernandez-Ranada J. Acute hepatitis and selective erythroblastopenia. Acta Haemat. 1983;69:141-2.
23. Tefferi A, Solberg LA Jr, Ellefson RD. Porphyrias: Clinical evaluation and interpretation of laboratory tests. Mayo Clin Proc. 1994;69:289-90.
24. Krantz SB. Pure red cell aplasia: Biology and treatment. In: Feig SA, Freedman MH; eds. Clinical Disorders and Experimental Models of Erythropoietic Failure. CRC Press, 1993: 85-127.
25. Harris JW. Parvovirus B19 for the hematologist. Amer J Hematol. 1992;39:119-30.
26. Lacombe C, Casadevall N, Muller O, Varet B. Erythroid progenitors in adult chronic pure red cell aplasia. Relationship of in vitro erythroid colonies to therapeutic response. Blood. 1984;64:71-7.
27. Abkowitz JL, Powell JS, Nakamura JM, Kadin ME, Adamson JW. Pure red cell aplasia: Response to therapy with anti-thymocyte globulin. Amer J Hematol. 1986;23:363-71.
28. Charles RJ, Sabo KM, Kidd PG, Abkowitz JL. The pathophysiology of pure red cell aplasia: Implications for therapy. Blood. 1996;87:4831-8.
29. Choo Q-L, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton, M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science. 1989;244:359-62.
30. Kuo G, Choo Q-L, Alter HJ, Gitnick GL, Redeker AG, Purcell RH, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science. 1989;244:362-4.
31. Alter HJ. To C or not to C: These are the questions. Blood. 1995;85:1681-95.
32. Sharara AI, Hunt CM, Hamilton JD. Hepatitis C. Ann Int Med. 1996;125:658-68.
33. Meyer zum Buschenfelde K-H, Lohse AW. Autoimmune hepatitis (editorial). N Engl J Med. 1995;333:1004-5.
34. Gumber SC, Chopra S. Hepatitis C: A multifaceted disease. Review of extrahepatic manifestations. Ann Intern Med. 1995;123:615-20.
35. Pawlotsky J-M, Roudot-Thoraval F, Simmonds P, Mellor J, Ben Yahia M, Andre C, et al. Extrahepatic immunologic manifestations in chronic hepatitis C and hepatitis C virus serologies. Ann Int Med. 1995;122:169-73.
36. Fargion A, Piperno A, Cappellini MD, Sampietro M, Fracanzani AL, Romano R, et al. Hepatitis C virus and porphyria cutanea tarda: Evidence of a strong association. Hepatology. 1992;16:1322-6.
37. DeCastro M, Sanchez J, Herrera JF, Chaves A, Duran R, Garcia-Buey L, et al. Hepatitis C virus antibodies and liver disease in patients with porphyria cutanea tarda. Hepatology. 1993;17:551-7.
38. Herrero C, Vincente A, Bruguera M, Ercilla MG, Barrera JM, Vidal J, et al. Is hepatitis C virus infection a trigger of porphyria cutanea tarda? Lancet. 1993;341:788-9.
39. Navas S, Bosch O, Castillo I, Marriott E, Carreno V. Porphyria cutanea tarda and hepatitis C and B viruses infection: A retrospective study. Hepatology. 1995;21:279-84.
40. Ferri C, Monti M, La Civita L, Longombardo G, Greco F, Pasero G, et al. Infection of peripheral blood mononuclear cells by hepatitis C virus in mixed cryoglobulinemia. Blood. 1993;82:3701-4.
41. Ferri C, Caracciolo F, Zignego AL, La Civita L, Monti M, Longombardo G, et al. Hepatitis C virus infection in patients with non-Hodgkin's lymphoma. Brit J Haematol. 1994;88:192-4.
42. De Vita S, Sansonno D, Dolcetti R, Ferraccioli G, Carbone A, Cornacchiulo V, et al. Hepatitis C virus within a malignant lymphoma lesion in the course of type II mixed cryoglobulinemia. Blood. 1995;86:1887-92.
43. Ferri C, La Civita L, Monti M, Longombardo G, Greco F, Pasero G, et al. Can type C hepatitis infection be complicated by malignant lymphoma? Lancet. 1995;346:1426-7.
44. Andreone P, Gramenzi A, Cursaro C, Bernardi M, Zignego AL. Monoclonal gammopathy in patients with chronic hepatitis C virus infection (letter). Blood. 1996;88:1122.
45. Mussini C, Ghini M, Mascia MT, Giovanardi P, Zanni G, Lattuada I, et al. Monoclonal gammopathies and hepatitis C virus infection. Blood. 1995;85:1144-5.
46. Silvestri F, Barillari G, Fanin R, Zaja F, Infanti L, Patriarca F, et al. Risk of hepatitis C virus infection, Waldenstrom's macroglobulinemia, and monoclonal gammopathies. Blood. 1996;88:1125-6.
47. Silva M, Li X, Cheinquer H, Kolodny L, Radick J, LaRue S, et al. HCV associated idiopathic thrombocytopenic purpura (ITP) (abstract). Gastroenterology. 1992;102(suppl):A889.
48. Weinberg RS, Goldberg JD, Schofield JM, Lenes AL, Styczynski R, Alter BP. Switch from fetal to adult hemoglobin is associated with a change in progenitor cell population. J Clin Invest. 1983;71:785-94.